Cardiovascular protective effect of sodium-glucose cotransporter 2 inhibitors on patients with acute coronary syndrome and type 2 diabetes mellitus: a retrospective study

BACKGROUND: Acute coronary syndrome (ACS) remains the leading cause of death and disability worldwide, especially when combined with type 2 diabetes mellitus (T2DM). Many multicenter randomized controlled trials have established the cardiovascular benefits of Sodium-Glucose cotransporter 2 inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jie, Chang, Jing, Shi, Qiuyue, Li, Xin, Wang, Ling, Zhao, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559512/
https://www.ncbi.nlm.nih.gov/pubmed/37805494
http://dx.doi.org/10.1186/s12872-023-03542-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10559512/
https://www.ncbi.nlm.nih.gov/pubmed/37805494
http://dx.doi.org/10.1186/s12872-023-03542-y

Ejemplares similares